Connaughton Bernadette 4
4 · HALOZYME THERAPEUTICS, INC. · Filed Sep 2, 2025
Insider Transaction Report
Form 4
Connaughton Bernadette
Director
Transactions
- Sale
Common Stock
2025-09-02$73.62/sh−2,977$219,161→ 47,875 total - Sale
Common Stock
2025-09-02$74.11/sh−923$68,404→ 46,952 total - Sale
Common Stock
2025-09-02$71.71/sh−100$7,171→ 50,852 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on May 29, 2025 in accordance with Rule 10b5-1.
- [F2]Represents a weighted average sales price per share. The shares were sold at prices ranging from $72.91 to $73.89. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]Represents a weighted average sales price per share. The shares were sold at prices ranging from $73.95 to $74.38. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.